How does PT-141 (Bremelanotide) work?
Melanocortin-receptor agonist (MC3R + MC4R) that acts centrally on arousal pathways in the brain rather than peripherally on blood flow (which is what PDE5 inhibitors like Viagra do). Different lever, desire vs vasodilation. In plain terms, PT-141 (Bremelanotide) is boosts libido and sexual desire. A melanocortin agonist, FDA-approved as Vyleesi for female sexual dysfunction and used off-label for libido in both sexes. Mechanistic detail like this comes largely from preclinical and early research, the human picture is limited.
What people use it for
- Users with situational or low-baseline libido
- Couples wanting a non-PDE5-inhibitor option
- People for whom Viagra/Cialis don't address the desire side
References
- Bremelanotide for HSDD in premenopausal women — Kingsberg SA et al., Obstet Gynecol, 2019
- Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide — Simon JA, Kingsberg SA, Portman D, et al.; Journal of Women's Health; 2022
- Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide — Althof S, Derogatis LR, Greenberg S, et al.; Journal of Sexual Medicine; 2019
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on PT-141 (Bremelanotide)
Last updated 2026-06-06.